Acquisition of LifeHealthcare, Equity Raising and Trading Update
EBOS Group Limited (EBOS) has entered into a share purchase agreement to acquire LifeHealthcare from Funds advised by Pacific Equity Partners and other minority holders, comprising 100% of LifeHealthcare’s Australian & New Zealand subsidiaries and 51% of LifeHealthcare’s Asian subsidiary, Transmedic (together, LifeHealthcare), for total consideration of approximately A$1,167 million (representing an enterprise value of approximately A$1,275 million on a 100% basis) subject to customary purchase price adjustments (the Acquisition or Transaction).
FUNDING
The Acquisition will be fully funded through a combination of the proceeds of a non-underwritten retail offer to eligible existing shareholders to raise up to A$100 million, with the ability to accept oversubscriptions at EBOS’ discretion, approximately A$642 million raised from the Placement, a new A$540 million term loan debt facility and approximately 0.7 million new EBOS shares issued to LifeHealthcare management (approximately $23 million ).
Please see attachments for full details.
The S&P/NZX 50 Index closed at 12.844.59, declining 60.45 points or 0.47%.
The CEO says Lyttelton Port does not generate sufficient returns on its capital base.
Falling market share and margins in the broadband market look entrenched.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details